-
Ralmitaront (INNTooltip
International Nonproprietary Name,
USANTooltip United States Adopted Name;
developmental code
names RG-7906 and RO-6889450) is...
- a
phase 1
trial was
reported to have been
completed by
October 2014.
Ralmitaront (RG-7906; RO-6889450) RG-7351
Ulotaront (SEP-363856; SEP-856) "RG 7410"...
-
reported since July 2016. The drug was
developed by Hoffmann-La Roche.
Ralmitaront (RG-7906; RO-6889450) RG-7410
Ulotaront (SEP-363856; SEP-856) "RG 7351"...
- D2,3, 5-HT7,
receptor antagonist (methylated
version of amisulpride)
Ralmitaront (RG-7906, RO-6889450) – TAAR1
agonist Ulotaront (SEP-856, SEP-363856)...
-
Methamphetamine 3-MMA
Norfenfluramine Phentermine o-PIT
Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RG-7351 RG-7410 RO-5166017 RO-5256390 RO-5263397...
-
Methamphetamine 3-MMA
Norfenfluramine Phentermine o-PIT
Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RG-7351 RG-7410 RO-5166017 RO-5256390 RO-5263397...
-
formula C17H22N4O2 (molar m****: 314.389 g/mol) may
refer to:
Resiquimod Ralmitaront This set
index page
lists chemical structure articles ****ociated with...
- microtubule-****ociated
protein (MAP)
stimulant and
tubulin polymerization promoter Ralmitaront (RG-7906; RO-6889450) –
trace amine-****ociated
receptor 1 (TAAR1) agonist...
- List of
investigational antipsychotics §
Monoamine receptor modulators Ralmitaront "International
Nonproprietary Names for
Pharmaceutical Substances (INN)"...
- agent.
Ulotaront (SEP-363856, SEP-856),
investigational antipsychotic.
Ralmitaront (RG-7906, RO-6889450),
investigational antipsychotic.
EPPTB or...
